PRELUDE CAPITAL MANAGEMENT, LLC - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 44 filers reported holding MIRAGEN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$38,000
+8.6%
6,000
+20.0%
0.00%
-33.3%
Q1 2018$35,000
-16.7%
5,000
+25.0%
0.00%0.0%
Q4 2017$42,000
-28.8%
4,000
-38.5%
0.00%
-40.0%
Q3 2017$59,000
-22.4%
6,500
+10.8%
0.01%
-28.6%
Q2 2017$76,000
+18.8%
5,867
+13.5%
0.01%
+16.7%
Q1 2017$64,0005,1670.01%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 105,465$965,0002.31%
BIEGEL & WALLER LLC 66,508$609,0000.38%
BSW Wealth Partners 22,236$203,0000.09%
Artal Group S.A. 100,000$915,0000.02%
PRIO WEALTH LIMITED PARTNERSHIP 12,895$117,0000.01%
Virtu Financial LLC 10,976$100,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 6,500$59,0000.01%
FMR LLC 3,124,888$28,593,0000.00%
SG Americas Securities, LLC 27,283$250,0000.00%
HighTower Advisors, LLC 21,034$194,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders